Cashman Neil
SEC insider (Form 3/4/5 filer). CIK 0001927064. Chief Scientific Officer at ProMIS Neurosciences Inc. (PMN). 5 reported Form 4/5 transactions since Sep 2024; latest on May 20, 2026. Located in TORONTO, A6.
Companies Cashman Neil has filed insider reports for
- ProMIS Neurosciences Inc. (PMN): Director, Officer, Chief Scientific Officer
Cashman Neil
CIK: 0001927064
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ProMIS Neurosciences Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 20, 2026PMN
ProMIS Neurosciences Inc.
AwardDirectOption (right to buy)
50K shares- - Feb 3, 2026PMN
ProMIS Neurosciences Inc.
AwardIndirect4.1K shares at avg. $12.13$50K - Sep 22, 2025PMN
ProMIS Neurosciences Inc.
AwardDirectOption (right to buy)
165K shares- - Feb 10, 2025PMN
ProMIS Neurosciences Inc.
PurchaseIndirect15K shares at avg. $0.97$15K - Nov 18, 2024PMN
ProMIS Neurosciences Inc.
AwardDirectOption (right to buy)
200K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 20, 2026 | PMN ProMIS Neurosciences Inc. | Award Option (right to buy) | 50,000 | - | - | Direct |
| Feb 3, 2026 | PMN ProMIS Neurosciences Inc. | Award | 4,122 | $12.13 | $50,000 | Indirect |
| Sep 22, 2025 | PMN ProMIS Neurosciences Inc. | Award Option (right to buy) | 165,000 | - | - | Direct |
| Feb 10, 2025 | PMN ProMIS Neurosciences Inc. | Purchase | 15,000 | $0.97 | $14,595 | Indirect |
| Nov 18, 2024 | PMN ProMIS Neurosciences Inc. | Award Option (right to buy) | 200,000 | - | - | Direct |
1-5 of 5 transactions